Optimal sequencing of the first- and second-line target therapies in metastatic renal cell carcinoma: based on nationally representative data analysis from the Korean National Health Insurance System

Optimal sequencing of the first- and second-line target therapies in metastatic renal cell carcinoma: based on nationally representative data analysis from the Korean National Health Insurance System

Abstract Background The authors intend to compare the effects of each targeted therapy (TT) in the treatment of patients with metastatic renal cell carcinoma (mRCC) using big data based on the Korean National Health Insurance System (NHIS) and determine the optimal treatment sequence. Methods Data o...

Full description

Bibliographic Details
Main Authors: Dong Hyuk Kang, Joo Yong Lee, Yunhee Lee, U-Syn Ha
Format: Article
Language:English
Published: BMC 2023-05-01
Series:BMC Cancer
Subjects:
Renal cell carcinoma
Sunitinib
Pazopanib
Axitinib
Cabozantinib
Online Access:https://doi.org/10.1186/s12885-023-10991-3

Similar Items

Similar Items